Israel to dose last BriLife Phase II trial participant on Sunday
The Phase II trial had been approved and kicked off in December 2020, around the time the first vaccines arrived in Israel
Hadassah-University Medical Center's Prof. Yossi Karko (left) and Hannah Drori, chief of the hospital’s clinical research center, administer Brilife vaccine to a volunteer(photo credit: HADASSAH)ByMAAYAN JAFFE-HOFFMAN
